GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Gallbladder and Pancreas/Selective Use of Biliary Drainage Supported in pCCA : BJS | Jun 2026

Selective Use of Biliary Drainage Supported in pCCA : BJS | Jun 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated June 1, 2026

Quick Answer

Introduction: Preoperative biliary drainage (PBD) is frequently used in patients with perihilar cholangiocarcinoma (pCCA) to relieve biliary obstruction before surgery. The proposed benefits include improved liver function, reduced jaundice, and optimization of the future liver remnant before major hepatectomy.


Introduction:

Preoperative biliary drainage (PBD) is frequently used in patients with perihilar cholangiocarcinoma (pCCA) to relieve biliary obstruction before surgery. The proposed benefits include improved liver function, reduced jaundice, and optimization of the future liver remnant before major hepatectomy. However, biliary drainage is also associated with procedure-related complications, infection, and potential delays to definitive surgery. As a result, its routine use remains controversial.

Problem Statement:

Current practice varies widely because there is no clear consensus regarding which patients with resectable pCCA truly benefit from preoperative biliary drainage. Determining whether drainage improves or worsens postoperative outcomes is critical for optimizing perioperative management and reducing surgical risk.

Summary:

This large international multicenter study evaluated the impact of preoperative biliary drainage on postoperative outcomes in patients undergoing resection for perihilar cholangiocarcinoma. After adjustment for important baseline differences, the investigators found that patients who underwent biliary drainage experienced higher rates of major postoperative complications and, most notably, a significantly increased risk of posthepatectomy liver failure. When additional multivariable analyses were performed, the association with posthepatectomy liver failure remained robust, suggesting that biliary drainage may contribute to adverse postoperative liver-related outcomes in selected patients. These findings challenge the traditional assumption that preoperative drainage is universally beneficial before major liver resection for pCCA. Importantly, the study does not imply that biliary drainage should be abandoned altogether. Rather, it highlights that a subset of patients with resectable disease may proceed safely to surgery without routine drainage. The results support a more individualized approach in which decisions are guided by factors such as bilirubin levels, cholangitis, anticipated future liver remnant volume, and planned extent of resection. Given the retrospective nature of the analysis, definitive conclusions regarding causality cannot be drawn. Nevertheless, this represents one of the largest studies addressing this question and provides important evidence that routine preoperative biliary drainage should be carefully reconsidered. Future prospective studies are needed to better define which patients derive genuine benefit from drainage before surgery for perihilar cholangiocarcinoma.

Related Q&A

Ivonescimab Plus Gemcitabine–Cisplatin in Biliary Tract Cancer (BTC): Journal of Hepatology | July 2026

Introduction: Advanced biliary tract cancer (BTC) carries a poor prognosis, with limited improvements in survival despite the addition of immune checkpoint inhibitors to standard gemcitabine–cisplatin chemotherapy. This phase II trial evaluated ivonescimab, a novel PD-1/VEGF...

GLP-1 Receptor Agonists and Gallbladder Disease: UEG Journal | June 2026

Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become a cornerstone in the management of type 2 diabetes because of their excellent glycemic, cardiovascular, and weight-loss benefits. However, concerns remain regarding their potential association with...

Remnant Duct Dilatation Rarely Signals IPMN Recurrence : Ann Surg | Jun 2026

Introduction: Patients undergoing pancreatoduodenectomy for non invasive intraductal papillary mucinous neoplasm (IPMN) require long-term surveillance because of the risk of disease recurrence in the pancreatic remnant. New pancreatic duct (PD) dilatation is commonly detected during...

Post-Pancreatectomy Chyle Leak: Annals of Surgery | June 2026

• This study evaluated 1,063 patients undergoing pancreatic surgery; 11% developed conventionally defined chyle leak. • Most clinically relevant cases were grade B, while no grade C leaks were reported. • A minimally invasive surgical...

Immediate Necrosectomy Accelerates Recovery in Walled-Off Necrosis : Gastroenterology | Jul 2026

Introduction: Endoscopic ultrasound (EUS)-guided drainage has become the preferred minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Fatty Pancreas: A Hidden Burden in T2DM : Diabetes Res Clin Pract | June 2026

Introduction: Fatty pancreas disease (FPD), also known as intrapancreatic fat deposition, has emerged as an important metabolic condition closely linked to obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). Although ectopic fat accumulation in...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer